tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pharming announces 20% net reduction in non-commercial, non-medical headcount
PremiumThe FlyPharming announces 20% net reduction in non-commercial, non-medical headcount
1M ago
Pharming Group’s Leniolisib Gains FDA Approval for Pediatric Use, Expanding Market Potential
Premium
Ratings
Pharming Group’s Leniolisib Gains FDA Approval for Pediatric Use, Expanding Market Potential
2M ago
Pharming Group’s Leniolisib Receives FDA Priority Review for Pediatric APDS Treatment
Premium
Company Announcements
Pharming Group’s Leniolisib Receives FDA Priority Review for Pediatric APDS Treatment
2M ago
Pharming price target raised to EUR 2.45 from EUR 2 at RBC Capital
PremiumThe FlyPharming price target raised to EUR 2.45 from EUR 2 at RBC Capital
4M ago
Pharming price target raised to $41 from $40 at Oppenheimer
Premium
The Fly
Pharming price target raised to $41 from $40 at Oppenheimer
4M ago
Pharming Group’s Strong Financial Performance and Strategic Developments Justify Buy Rating
Premium
Ratings
Pharming Group’s Strong Financial Performance and Strategic Developments Justify Buy Rating
4M ago
Pharming Group Announces Key Board Appointments and Approvals at 2025 AGM
PremiumCompany AnnouncementsPharming Group Announces Key Board Appointments and Approvals at 2025 AGM
5M ago
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
6M ago
Pharming Group Reports Strong Q1 2025 Revenue Growth
Premium
Company Announcements
Pharming Group Reports Strong Q1 2025 Revenue Growth
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100